Product
Belcesiran
1 clinical trial
1 indication
Indication
Alpha-1 Antitrypsin DeficiencyClinical trial
A Phase 2, Randomized, Double-blind, Placebo-Controlled Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Dose Levels of Belcesiran in Patients With Alpha-1 Antitrypsin Deficiency-Associated Liver DiseaseStatus: Active (not recruiting), Estimated PCD: 2023-12-08